Align Technology, Inc.

ALGN ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $231.4M $189.7M $144.0M $145.8M $64.3M $58.7M $66.7M $74.3M
Depreciation & Amortization $37.7M $24.0M $18.0M $17.9M $16.8M $17.8M $12.1M $11.4M
Depreciation — — — — — — — —
Amortization $6.2M $3.2M — — $2.9M $4.4M $5.4M $2.8M
Stock-Based Compensation $58.9M $54.1M $52.9M $39.8M $26.4M $21.5M $19.2M $16.1M
Net Cash from Operating Activities $438.5M $247.7M $238.0M $226.9M $186.0M $133.8M $130.5M $129.5M
Investing Activities
Capital Expenditures $195.7M $70.6M $53.5M $24.1M $19.4M $38.3M $30.4M $18.0M
Business Acquisitions $9.0M $0 $0 $0 $7.7M $0 $187.6M $0
Net Cash from Investing Activities $-251.5M $73.0M $-166.4M $-201.6M $-210.7M $-78.3M $-211.6M $-15.9M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $103.8M $96.2M $101.8M $98.2M $95.1M $47.2M $7.8M $0
Net Cash from Financing Activities $-135.5M $-95.5M $-100.8M $-66.4M $-38.2M $10.2M $27.2M $14.7M
Net Change in Cash $57.1M $221.8M $-32.2M $-43.1M $-63.4M $65.7M $-54.0M $128.2M
Free Cash Flow $242.8M $177.1M $184.5M $202.8M $166.6M $95.4M $100.1M $111.5M
← Newer Page 2 of 3 Older →